WO2023077291A1 - Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide - Google Patents
Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide Download PDFInfo
- Publication number
- WO2023077291A1 WO2023077291A1 PCT/CN2021/128346 CN2021128346W WO2023077291A1 WO 2023077291 A1 WO2023077291 A1 WO 2023077291A1 CN 2021128346 W CN2021128346 W CN 2021128346W WO 2023077291 A1 WO2023077291 A1 WO 2023077291A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- parts
- skin
- barrier
- skin care
- combination
- Prior art date
Links
- 230000004888 barrier function Effects 0.000 title claims abstract description 159
- 239000000203 mixture Substances 0.000 title claims abstract description 143
- 238000002360 preparation method Methods 0.000 title claims abstract description 76
- 238000004519 manufacturing process Methods 0.000 title description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000002994 raw material Substances 0.000 claims abstract description 37
- 150000003839 salts Chemical class 0.000 claims abstract description 25
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 18
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 18
- 229940106189 ceramide Drugs 0.000 claims abstract description 18
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 18
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 159000000007 calcium salts Chemical class 0.000 claims abstract description 15
- 159000000003 magnesium salts Chemical class 0.000 claims abstract description 15
- 159000000000 sodium salts Chemical class 0.000 claims abstract description 15
- 150000002696 manganese Chemical class 0.000 claims abstract description 14
- 229920000289 Polyquaternium Polymers 0.000 claims abstract description 10
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims abstract description 10
- 230000008439 repair process Effects 0.000 claims description 117
- 235000002639 sodium chloride Nutrition 0.000 claims description 31
- 239000004359 castor oil Substances 0.000 claims description 23
- 235000019438 castor oil Nutrition 0.000 claims description 23
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 23
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 20
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 19
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 18
- WMPGRAUYWYBJKX-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO WMPGRAUYWYBJKX-UHFFFAOYSA-N 0.000 claims description 17
- 244000068988 Glycine max Species 0.000 claims description 17
- 235000010469 Glycine max Nutrition 0.000 claims description 17
- 150000002148 esters Chemical class 0.000 claims description 17
- 239000004006 olive oil Substances 0.000 claims description 17
- 235000008390 olive oil Nutrition 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 235000019198 oils Nutrition 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 16
- 239000005018 casein Substances 0.000 claims description 15
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 15
- 235000021240 caseins Nutrition 0.000 claims description 15
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 14
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 14
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 14
- 238000000855 fermentation Methods 0.000 claims description 14
- 230000004151 fermentation Effects 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 14
- 102000011632 Caseins Human genes 0.000 claims description 13
- 108010076119 Caseins Proteins 0.000 claims description 13
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 12
- IGFHQQFPSIBGKE-UHFFFAOYSA-N 4-nonylphenol Chemical compound CCCCCCCCCC1=CC=C(O)C=C1 IGFHQQFPSIBGKE-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 229960005323 phenoxyethanol Drugs 0.000 claims description 12
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 12
- 239000004299 sodium benzoate Substances 0.000 claims description 12
- 235000010234 sodium benzoate Nutrition 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 239000002270 dispersing agent Substances 0.000 claims description 8
- 239000004744 fabric Substances 0.000 claims description 8
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims description 8
- 244000284012 Vetiveria zizanioides Species 0.000 claims description 7
- 235000007769 Vetiveria zizanioides Nutrition 0.000 claims description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 7
- 235000010216 calcium carbonate Nutrition 0.000 claims description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 7
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 7
- 229940099596 manganese sulfate Drugs 0.000 claims description 7
- 239000011702 manganese sulphate Substances 0.000 claims description 7
- 235000007079 manganese sulphate Nutrition 0.000 claims description 7
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 7
- 239000001103 potassium chloride Substances 0.000 claims description 7
- 235000011164 potassium chloride Nutrition 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 5
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 159000000001 potassium salts Chemical class 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 4
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 2
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 2
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims description 2
- 244000131522 Citrus pyriformis Species 0.000 claims description 2
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 102000004895 Lipoproteins Human genes 0.000 claims description 2
- 108090001030 Lipoproteins Proteins 0.000 claims description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 244000044822 Simmondsia californica Species 0.000 claims description 2
- 235000004433 Simmondsia californica Nutrition 0.000 claims description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 2
- 229930182558 Sterol Natural products 0.000 claims description 2
- 102000004142 Trypsin Human genes 0.000 claims description 2
- 108090000631 Trypsin Proteins 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 2
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001102 lavandula vera Substances 0.000 claims description 2
- 235000018219 lavender Nutrition 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
- 235000011147 magnesium chloride Nutrition 0.000 claims description 2
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 claims description 2
- 239000004137 magnesium phosphate Substances 0.000 claims description 2
- 229910000157 magnesium phosphate Inorganic materials 0.000 claims description 2
- 229960002261 magnesium phosphate Drugs 0.000 claims description 2
- 235000010994 magnesium phosphates Nutrition 0.000 claims description 2
- 239000011656 manganese carbonate Substances 0.000 claims description 2
- 235000006748 manganese carbonate Nutrition 0.000 claims description 2
- 229940093474 manganese carbonate Drugs 0.000 claims description 2
- 239000011565 manganese chloride Substances 0.000 claims description 2
- 235000002867 manganese chloride Nutrition 0.000 claims description 2
- 229940099607 manganese chloride Drugs 0.000 claims description 2
- 229940077478 manganese phosphate Drugs 0.000 claims description 2
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 claims description 2
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 235000011181 potassium carbonates Nutrition 0.000 claims description 2
- 229910000160 potassium phosphate Inorganic materials 0.000 claims description 2
- 235000011009 potassium phosphates Nutrition 0.000 claims description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 2
- 235000011151 potassium sulphates Nutrition 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 2
- 239000001488 sodium phosphate Substances 0.000 claims description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 2
- 235000011152 sodium sulphate Nutrition 0.000 claims description 2
- 150000003432 sterols Chemical class 0.000 claims description 2
- 235000003702 sterols Nutrition 0.000 claims description 2
- 150000005846 sugar alcohols Polymers 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 2
- 239000012588 trypsin Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract description 38
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 19
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract description 19
- 235000019152 folic acid Nutrition 0.000 abstract description 19
- 239000011724 folic acid Substances 0.000 abstract description 19
- 229960000304 folic acid Drugs 0.000 abstract description 19
- 239000008103 glucose Substances 0.000 abstract description 19
- 229920005862 polyol Polymers 0.000 abstract description 14
- 150000003077 polyols Chemical class 0.000 abstract description 14
- 230000000813 microbial effect Effects 0.000 abstract description 10
- 231100000344 non-irritating Toxicity 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 150000002632 lipids Chemical class 0.000 abstract description 4
- 230000001502 supplementing effect Effects 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 164
- 239000000047 product Substances 0.000 description 86
- 238000012360 testing method Methods 0.000 description 33
- 230000000052 comparative effect Effects 0.000 description 31
- 241000894006 Bacteria Species 0.000 description 23
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 18
- 230000000694 effects Effects 0.000 description 18
- 230000007794 irritation Effects 0.000 description 15
- 244000005700 microbiome Species 0.000 description 14
- 241000186660 Lactobacillus Species 0.000 description 13
- 235000001727 glucose Nutrition 0.000 description 13
- 229940039696 lactobacillus Drugs 0.000 description 12
- 238000001816 cooling Methods 0.000 description 10
- 239000006041 probiotic Substances 0.000 description 10
- 235000018291 probiotics Nutrition 0.000 description 10
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 9
- 229940004120 bifidobacterium infantis Drugs 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- 210000001519 tissue Anatomy 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 230000008591 skin barrier function Effects 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 229910017053 inorganic salt Inorganic materials 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 206010015946 Eye irritation Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 231100000013 eye irritation Toxicity 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 4
- 240000001046 Lactobacillus acidophilus Species 0.000 description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 210000001643 allantois Anatomy 0.000 description 4
- 210000004381 amniotic fluid Anatomy 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 4
- 244000005714 skin microbiome Species 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 102000003886 Glycoproteins Human genes 0.000 description 3
- 108090000288 Glycoproteins Proteins 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 210000000245 forearm Anatomy 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 231100000286 mucous membrane, eye irritation or corrosion testing Toxicity 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000036572 transepidermal water loss Effects 0.000 description 3
- AAOFEMJZTYQZRH-UHFFFAOYSA-N 2-(1-butoxypropan-2-yloxy)ethanol Chemical compound CCCCOCC(C)OCCO AAOFEMJZTYQZRH-UHFFFAOYSA-N 0.000 description 2
- AWFYPPSBLUWMFQ-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=C2 AWFYPPSBLUWMFQ-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241000980781 Cladosiphon Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 210000003711 chorioallantoic membrane Anatomy 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 210000004087 cornea Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 229940047663 ppg-26-buteth-26 Drugs 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- CCOQPGVQAWPUPE-UHFFFAOYSA-N 4-tert-butylcyclohexan-1-ol Chemical compound CC(C)(C)C1CCC(O)CC1 CCOQPGVQAWPUPE-UHFFFAOYSA-N 0.000 description 1
- 229940091886 4-tert-butylcyclohexanol Drugs 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 description 1
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 101100474383 Escherichia coli (strain K12) rpsO gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 231100000490 OECD 405 Acute Eye Irritation/Corrosion Toxicity 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940023064 escherichia coli Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- -1 manganese salts Chemical class 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011076 safety test Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002602 strong irritant Substances 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- the application belongs to the technical field of daily chemicals, and in particular relates to a barrier repair composition, a skin care product, a preparation method thereof, and an application in the preparation of wet wipes.
- the skin covers the surface of the human body and is the largest organ of the human body. It has the functions of barrier, absorption, excretion, and temperature regulation, among which the barrier function is the foundation.
- the barrier function of the skin mainly means that the skin can protect the subcutaneous organs and tissues of the human body from harmful factors such as mechanical, physical, and chemical factors in the external environment.
- a healthy skin barrier can effectively prevent the loss of various nutrients, electrolytes, and water in the tissue.
- Barrier repair is mainly through the adjustment of three major balances: the balance of metabolism, the balance of water and oil, and the balance of microecology.
- the surface of human skin carries more than 1,000 kinds of microorganisms, about 80% of which are bacteria; bacteria that settle on the surface of the skin can usually be divided into resident flora and transient flora, and the resident flora colonizes the skin in an orderly manner
- a layer of biological barrier is formed, so that pathogenic bacteria and foreign bacteria cannot gain a foothold in the skin.
- the micro-ecological balance maintains the resident bacteria of the skin in a suitable state, prevents the loss of transepidermal water evaporation, and enhances the skin's resistance to pathogenic diseases.
- the ability and moisturizing ability of bacteria and foreign bacteria have become a crucial means.
- amniotic fluid environment of the mother provides a mild and safe living environment for the baby. Simulating the composition and concentration of the amniotic fluid to build a safe and effective system to build the biological barrier of the skin and strengthen the physical barrier of the skin has become a new skin care direction.
- CN105919819A discloses a napkin care wet tissue for infants and young children based on polyionized water, which includes polyionized water and an acidic chelating agent.
- the buttock care wet tissue has a good cleaning and sterilization effect, but it is easy to cause excessive cleaning and sterilization, and the skin feel is poor, and it is easy to cause damage to the fragile skin of infants and young children.
- CN104173207A discloses a skin barrier repairing preparation and a preparation method thereof.
- the skin barrier repairing preparation includes deionized water, sucrose stearate, vitamin E, butylene glycol, glycerin, sodium hyaluronate and the like.
- the skin barrier repair composition has a good effect of regulating the lipid content of the skin, but has a single function, has no bactericidal effect, and cannot maintain the micro-ecological balance of the skin; and the preparation process of the natural extract is complicated.
- CN109172432A discloses a moisturizing and repairing composition, which comprises Cladosiphon Novae-Caledoniae (CLADOSIPHON NOVAE-CALEDONIAE) extract and lactobacillus/soybean milk fermentation product filtrate; the moisturizing repairing composition has good moisturizing effect, It can effectively adjust the water-oil balance of the skin, thereby repairing the skin barrier, but it has a single function and has no effect on regulating the skin flora, and a large amount of absolute ethanol is used in the preparation process, so the safety needs to be considered.
- CLADOSIPHON NOVAE-CALEDONIAE Cladosiphon Novae-Caledoniae
- CN105769713A discloses a baby skin care softening lotion, a baby skin care soft wet tissue and a preparation process thereof, the baby skin care lotion contains 0.01wt%-5wt% of nursing ingredients and 0.001wt%-0.3wt% of bactericidal ingredients ; wherein, the nursing ingredients are composed of vitamin E, licorice extract, and olive extract, and the weight ratio of the vitamin E, licorice extract, and olive extract is 0.01-0.5%:0.1-3%:0.1- 3%.
- the baby skin care lotion has a bactericidal effect, the addition of a bactericide may cause damage to the baby's skin; and the effect is single, unable to establish a biological barrier and maintain the micro-ecological balance of the skin.
- CN104887568A discloses a pure plant wet wipe, which is composed of a fully degradable non-woven fabric and a wet wipe liquid, which includes water, xylitol, licorice extract, aloe vera and vitamin E.
- a pure plant wet wipe has no harm to human skin, it cannot promote the growth of beneficial bacteria on the skin surface of infants and young children, and cannot build a microbial barrier; and it cannot supplement the lipid components between keratinocytes, nourish the skin, and build a physical barrier for the skin.
- CN105663018A discloses a cosmetic composition
- a cosmetic composition comprising water, 4-tert-butylcyclohexanol, plankton extract, aloe extract and zucchini seed extract.
- the main function of the cosmetic composition is to remove the stratum corneum, and the purpose is to maintain the metabolic balance of the stratum corneum, thereby repairing the skin barrier.
- the present application provides a barrier repairing composition, a skin care product, a preparation method thereof, and an application in preparing wet wipes.
- the barrier repairing composition provided by this application is safe and non-irritating. By promoting the growth of beneficial bacteria and inhibiting the growth of harmful microorganisms, the microbial barrier on the skin surface is established; by supplementing nutrition and moisture to the skin, the physical barrier of the skin is enhanced.
- the present application provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include by weight parts:
- the inorganic salts include calcium salts, magnesium salts, potassium salts, sodium salts and manganese salts.
- the barrier function of the skin mainly means that the skin can protect the subcutaneous organs and tissues of the human body from harmful factors such as mechanical, physical, and chemical factors in the external environment.
- a healthy skin barrier can effectively prevent the loss of various nutrients, electrolytes, and water in the tissue.
- Human skin needs to resist various harmful substances or ultraviolet rays in the daily environment, and the skin barrier is gradually damaged, so barrier repair is an important direction of skin care.
- Barrier repair is mainly through the adjustment of three major balances: the balance of newborn and fading, the balance of water and oil, and the balance of microecology.
- water, inorganic salts, glucose, protein and folic acid cooperate synergistically, while ensuring safety and reliability, it can effectively promote the growth of probiotics on the skin surface, promote the establishment of micro-ecological balance on the skin surface, inhibit The growth of harmful microorganisms builds the microbial barrier of the skin; it also nourishes the skin, balances oil, promotes the absorption of water and nutrients, and makes the skin elastic.
- water is used as a solvent, mild and non-irritating; inorganic salts can clean the skin, balance the water-oil balance of the skin, and can inhibit the growth of harmful microorganisms; glucose can enhance skin resistance, activate skin cells, promote collagen synthesis, and enhance Skin elasticity, in addition, it can also play the role of anti-allergic and sunscreen, can enhance the skin's ability to resist ultraviolet rays, can also increase the renewal speed of the cuticle of the skin, and promote wound healing; protein can enhance the immune function of the skin and promote beneficial bacteria on the skin
- the growth of the skin can regulate skin moisture and acid-base, and can balance oil, improve skin condition, and can enhance the function of the lymphatic system, improve the anti-allergic ability of sensitive skin, and can also chelate with divalent metal ions in the inner layer of the skin Reaction, prevent excessive divalent metal ions from cross-linking with collagen in the skin, maintain enough collagen fibers and elastic fibers, make the skin smooth, delicate and elastic, and prevent wrinkles; folic acid
- the parts by weight of the inorganic salt are 0.01-9 parts, such as 0.01 parts, 0.1 parts, 0.5 parts, 1 part, 2 parts, 3 parts, 4 parts parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, etc.
- the parts by weight of the glucose are 0.1-1 parts, such as 0.1 parts, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, 0.7 parts , 0.8 parts, 0.9 parts, 1 part, etc.
- the parts by weight of the protein are 0.5-2 parts, such as 0.5 parts, 0.7 parts, 0.9 parts, 1.1 parts, 1.3 parts, 1.5 parts, 1.7 parts , 2 copies, etc.
- the weight part of the folic acid is 0.0001-0.5 parts, for example, it can be 0.0001 parts, 0.01 parts, 0.05 parts, 0.09 parts, 0.1 parts, 0.2 parts, 0.3 parts , 0.4 parts, 0.5 parts, etc.
- the weight part of the polyol is 0.01-0.5 parts, such as 0.01 parts, 0.05 parts, 0.1 parts, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts portion etc.
- the parts by weight of the water are 800-1200 parts, such as 800 parts, 850 parts, 900 parts, 950 parts, 1000 parts, 1050 parts, 1100 parts, 1150 parts , 1200 copies, etc.
- the weight ratio of the calcium salt, magnesium salt, potassium salt, sodium salt and manganese salt is (0.01-0.2):(0.01-0.1):(0.2-0.6): (4-8):(0.01-0.1), such as 0.01:0.01:0.2:4:0.01, 0.01:0.05:0.3:5:0.05, 0.05:0.08:0.5:7:0.1, 0.1:0.09:0.4 :6:0.04, 0.2:0.1:0.6:8:0.1, etc.
- the concentration of the inorganic salt in the composition can be made to be similar to the concentration of the inorganic salt in the amniotic fluid, thereby better caring for the skin.
- the calcium salt includes any one or a combination of at least two of calcium carbonate, calcium chloride, calcium sulfate or calcium phosphate.
- the magnesium salt includes any one or a combination of at least two of magnesium sulfate, magnesium chloride, magnesium carbonate or magnesium phosphate.
- the potassium salt includes any one or a combination of at least two of potassium chloride, potassium carbonate, potassium sulfate or potassium phosphate.
- the sodium salt includes any one or a combination of at least two of sodium chloride, sodium carbonate, sodium sulfate or sodium phosphate.
- the manganese salt includes any one or a combination of at least two of manganese chloride, manganese carbonate, manganese sulfate or manganese phosphate.
- the protein includes any one or a combination of at least two of casein, glycoprotein, lipoprotein, trypsin or pancreatic casein, preferably casein.
- casein is a protein containing phosphorus and calcium. Casein can cooperate with inorganic salts, glucose and folic acid to promote the growth of beneficial bacteria, resist external harmful microorganisms, and jointly build a microbial barrier on the skin surface.
- the polyhydric alcohol includes any one or a combination of at least two of glycerin, 1,3-butanediol or 1,3-propanediol.
- polyols can absorb water from the environment and supplement the skin, and at the same time have a certain effect of inhibiting the growth of harmful microorganisms.
- the raw materials for the preparation of the barrier repair composition further include any one or a combination of at least two of Bacillus/soybean fermentation product extract and/or sodium hyaluronate.
- the Bacillus/soybean fermentation extract uses soybeans as raw materials to cultivate Bacillus and extract the metabolites of Bacillus.
- Soybean fermentation products are rich in nutrients, which can nourish the skin, promote metabolism, and condition the skin; hyaluronic acid Sodium is an inherent biological substance of the skin.
- Exogenous sodium hyaluronate can supplement the endogenous sodium hyaluronate of the skin.
- Sodium hyaluronate can penetrate into the epidermis of the skin to promote the supply of skin nutrients and the excretion of waste, and Sodium hyaluronate has a strong moisturizing effect.
- sodium hyaluronate can promote the proliferation and differentiation of epidermal cells, as well as scavenge oxygen free radicals, which can promote the regeneration of injured skin.
- the parts by weight of the Bacillus/soybean fermentation product extract are 0.001-0.05 parts, such as 0.001 parts, 0.005 parts, 0.007 parts, 0.01 parts, 0.02 parts, 0.03 parts, 0.04 parts, 0.05 parts, etc. .
- the weight part of the sodium hyaluronate is 0.001-0.05 parts, such as 0.001 parts, 0.005 parts, 0.007 parts, 0.01 parts, 0.02 parts, 0.03 parts, 0.04 parts, 0.05 parts, etc.
- the molecular weight of the sodium hyaluronate is 1800000-2200000Da, such as 1800000Da, 1900000Da, 2000000Da, 2100000Da, 22000000Da, etc.
- the preparation raw materials of the barrier repair composition include by weight parts:
- the water, glucose, inorganic salts, protein, folic acid, polyols, Bacillus/soybean fermentation product extract and sodium hyaluronate in the barrier repair composition cooperate synergistically, under the condition of ensuring safety and non-irritation , can further promote the skin's absorption of moisture and nutrients, making the skin supple, smooth and elastic, and can strengthen the skin's ability to resist external damage, inhibit the invasion of harmful microorganisms, promote the growth of probiotics, and maintain the ecological balance of the skin surface .
- the weight part of the calcium salt is 0.01-0.2 parts, such as 0.01 parts, 0.05 parts, 0.1 parts, 0.15 parts, 0.2 parts, etc.
- the weight part of the magnesium salt is 0.01-0.1 part, such as 0.01 part, 0.03 part, 0.05 part, 0.07 part, 0.1 part and so on.
- the weight part of the potassium salt is 0.2-0.6 parts, such as 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, 0.6 parts, etc.
- the weight part of the sodium salt is 4-8 parts, such as 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, etc.
- the manganese salt may be in parts by weight of 0.01-0.1 part, for example, 0.01 part, 0.03 part, 0.05 part, 0.07 part, 0.1 part, etc.
- the present application provides a skin care product.
- the preparation raw materials of the skin care product include: oil, ceramide, polyquaternium salt, the barrier repair composition as described in the first aspect, and water.
- the barrier repairing composition is used in combination with oil, ceramide and polyquaternium salts, which can maintain the ecological balance of the skin surface, promote the growth of beneficial bacteria, and inhibit the growth of harmful bacteria while ensuring safety and non-irritation.
- the growth of microorganisms builds a biological barrier; it can also supplement the lipid components between cuticles to enhance the physical barrier of the skin care products described in this application.
- oil can not only clean the skin, but also has the effect of moisturizing, moisturizing and whitening, and can give the skin a certain degree of elasticity and luster; ceramide can promote the metabolism of skin cells, repair the skin barrier, and effectively relieve acne, and to a certain extent It can accelerate the disappearance of acne marks; in addition, ceramide also has the effect of moisturizing and locking water, which can effectively improve the phenomenon of dry and peeling skin, thereby slowing down the appearance of fine lines; polyquaternium salt has good wettability, Soft and film-forming, can form a film on the skin surface, making the skin supple and smooth.
- the raw materials for the preparation of skin care products described in this application include by parts by weight:
- the weight fraction of the oil is 1-5 parts, for example, it can be 1 part, 2 parts, 3 parts, 4 parts, 5 parts, etc.
- the weight part of the ceramide is 0.1-0.5 parts, such as 0.1 parts, 0.2 parts, 0.3 parts, 0.4 parts, 0.5 parts, etc.
- the parts by weight of the polyquaternium salt are 0.1-1 part, such as 0.1 part, 0.2 part, 0.3 part, 0.4 part, 0.5 part, 0.6 part, 0.7 part, 0.8 part parts, 0.9 parts, 1 part, etc.
- the parts by weight of the barrier repair composition are 30-40 parts, such as 30 parts, 31 parts, 32 parts, 33 parts, 34 parts, 35 parts, 36 parts, 37 parts parts, 38 parts, 39 parts, 40 parts, etc.
- the parts by weight of the water are 50-75 parts, such as 50 parts, 52 parts, 54 parts, 56 parts, 58 parts, 60 parts, 62 parts, 64 parts, 66 parts parts, 68 parts, 70 parts, 73 parts, 75 parts, etc.
- the oil includes any one of PEG-7 olive oil ester, hydrolyzed jojoba ester, PEG-10 wild soybean sterol or laureth-12/White Pond Seed Oil or A combination of at least two, preferably a combination of PEG-7 Olivate and Laureth-12/White Pond Seed Oil.
- PEG-7 olive oil ester and laureth-12/white pond flower seed oil are used together to synergize. While replenishing skin moisture, it can also enhance the skin's antioxidant capacity. In addition, it can also Provides a refreshing skin feel.
- PEG-7 olive oil ester is a derivative of olive oil, and the skin feels refreshing and supple;
- laureth-12/white pond flower seed oil is a derivative of white pond flower seed oil, which contains a large amount of anti-oxidant Long-chain fatty acids, and the exfoliating hormone in the white pond flower seed oil can prevent water loss and regenerate the skin.
- the white pond flower seed oil can adjust the exudation of water and compounds by changing the keratin tissue, reabsorb water and regenerate the cells in the epidermis Hydrates to lock moisture in the epidermis of the skin.
- the weight ratio of the PEG-7 olive oil ester and laureth-12/white pond flower seed oil is 1:(0.8-1.2), such as 1:0.8, 1:0.9, 1:1 , 1:1.1, 1:1.2, etc.
- the polyquaternium salt includes any one or a combination of at least two of polyquaternium-10, polyquaternium-4 or polyquaternium-57.
- polyquaternium-57 can provide slippery skin feel while having good moisturizing properties.
- the preparation raw materials of the skin care product further include any one or a combination of at least two of preservatives, flavoring agents or dispersants.
- the preservative includes any one or a combination of at least two of 1,2-hexanediol, sodium benzoate, phenoxyethanol or hydroxyacetophenone, preferably a combination of sodium benzoate and phenoxyethanol.
- the combined use of sodium benzoate and phenoxyethanol can effectively control the production of more bacteria in skin care products and avoid the deterioration of skin care products; it can also penetrate the cell membrane and enter the cell body to play a role in sterilization and antibacterial. It is a relatively safe preservative.
- the weight ratio of sodium benzoate to phenoxyethanol is 1:(0.8-1.2), for example, it can be 1:0.8, 1:0.9, 1:1, 1:1.1, 1:1.2, etc.
- the weight part of the preservative is 0.3-1 part, such as 0.3 part, 0.5 part, 0.7 part, 0.9 part, 1 part, etc.
- the flavoring agent includes any one or a combination of at least two of vetiver essential oil, lemon essential oil or lavender essential oil.
- the parts by weight of the flavoring agent are 0.005-0.05 parts, such as 0.005 parts, 0.009 parts, 0.011 parts, 0.017 parts, 0.02 parts, 0.027 parts, 0.03 parts, 0.036 parts, 0.04 parts, 0.044 parts , 0.05 copies, etc.
- the dispersant includes PEG-40 hydrogenated castor oil, PPG-26 butane-26/PEG-40 hydrogenated castor oil, PEG-35 castor oil/PEG-50 hydrogenated castor oil/nonylphenol polyether -12. Any one or a combination of at least two of PEG-50 hydrogenated castor oil/nonylphenol polyether-25, preferably PEG-40 hydrogenated castor oil;
- PPG-26 buteth-26/PEG-40 hydrogenated castor oil means the combination of PPG-26 buteth-26 and PEG-40 hydrogenated castor oil;
- Alcohol-26/PEG-40 hydrogenated castor oil, PEG-35 castor oil/PEG-50 hydrogenated castor oil/nonylphenol polyether-12, PEG-50 hydrogenated castor oil/nonylphenol polyether-25 are all Conventional products available commercially.
- the weight fraction of the dispersant is 0.01-0.05 parts, such as 0.01 parts, 0.011 parts, 0.017 parts, 0.02 parts, 0.027 parts, 0.03 parts, 0.036 parts, 0.04 parts, 0.044 parts, 0.05 parts, etc.
- the present application provides a method for preparing a skin care product as described in the second aspect, the method for preparing a skin care product includes the following steps:
- step (2) The water phase obtained in step (1), oil, ceramide, polyquaternium salt and barrier repair composition are mixed, homogenized, and filtered to obtain the skin care product.
- the heating temperature is 80-90°C; for example, it can be 80°C, 81°C, 82°C, 83°C, 84°C, 85 °C, 86°C, 87°C, 88°C, 89°C, 90°C, etc.
- the incubation time is 20-40min, such as 20min, 22min, 24min, 26min, 28min, 30min, 32min, 34min, 36min, 38min, 40min, etc.
- the mixing further includes any one or a combination of at least two of preservatives, flavoring agents or dispersants.
- the mixing temperature is 25-45°C, such as 25°C, 27°C, 29°C, 31°C, 33°C, 35°C, 37°C, 39°C, 41°C, 43°C, 45°C, etc.; the time is 10-30min, such as 10min, 12min, 14min, 16min, 18min, 20min, 22min, 24min, 26min, 28min, 30min, etc.
- the homogeneous temperature is 25-45°C, such as 25°C, 27°C, 30°C, 33°C, 35°C, 37°C, 40°C, 42°C, 45°C etc.; the time is 3-8 minutes, for example, it can be 3 minutes, 5 minutes, 6 minutes, 7 minutes, 8 minutes, etc.
- the filter cloth is 500-1000 mesh, such as 500 mesh, 600 mesh, 700 mesh, 800 mesh, 900 mesh, 1000 mesh, etc.
- the present application provides a barrier repair composition as described in the first aspect, or an application of the skin care product as described in the second aspect in the preparation of wet wipes.
- the barrier repair composition described in the application can promote the growth of probiotics on the surface of human skin, inhibit the growth of harmful microorganisms, thereby promoting the establishment of micro-ecological balance on the surface of the skin, thereby establishing a microbial barrier on the surface of the skin;
- the barrier repair composition described in this application can enhance the physical barrier of the skin by supplementing nutrition and moisture to the skin;
- Fig. 1 is a schematic diagram of the effect of the barrier repair composition provided by Examples 1-16 and Comparative Examples 1-10 on the growth of Escherichia coli.
- Fig. 2 is a schematic diagram of the effect of the barrier repair composition provided by Examples 1-16 and Comparative Examples 1-10 on the growth of Lactobacillus.
- Fig. 3 is a schematic diagram of the effect of the barrier repair composition provided by Examples 1-16 and Comparative Examples 1-10 on the growth of Lactobacillus acidophilus.
- Fig. 4 is a schematic diagram of the influence of the skin care products provided by Application Examples 1-9 and Comparative Examples 1-3 on the average water loss.
- Part source of components is as follows in the following examples:
- This embodiment provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include the following composition in parts by weight:
- the preparation method of the barrier repair composition comprises the following steps: heating the deionized water to 82°C according to the formula amount, then cooling down to 37°C, and mixing with calcium carbonate, magnesium sulfate, potassium chloride, sodium chloride, manganese sulfate, glucose , casein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate are mixed to obtain the barrier repair composition.
- This embodiment provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include the following composition in parts by weight:
- the preparation method of the barrier repair composition comprises the following steps: heating the deionized water to 82°C according to the formula amount, then cooling down to 37°C, and mixing with calcium carbonate, magnesium sulfate, potassium chloride, sodium chloride, manganese sulfate, glucose , casein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate are mixed to obtain the barrier repair composition.
- This embodiment provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include the following composition in parts by weight:
- the preparation method of the barrier repair composition comprises the following steps: heating the deionized water to 82°C according to the formula amount, then cooling down to 37°C, and mixing with calcium carbonate, magnesium sulfate, potassium chloride, sodium chloride, manganese sulfate, glucose , casein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate are mixed to obtain the barrier repair composition.
- This embodiment provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include the following composition in parts by weight:
- the preparation method of the barrier repair composition comprises the following steps: heating the deionized water to 82°C according to the formula amount, then cooling down to 37°C, and mixing with calcium carbonate, magnesium sulfate, potassium chloride, sodium chloride, manganese sulfate, glucose , casein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate are mixed to obtain the barrier repair composition.
- This embodiment provides a barrier repair composition
- the preparation raw materials of the barrier repair composition include the following composition in parts by weight:
- the preparation method of the barrier repair composition comprises the following steps: heating the deionized water to 82°C according to the formula amount, then cooling down to 37°C, and mixing with calcium carbonate, magnesium sulfate, potassium chloride, sodium chloride, manganese sulfate, glucose , casein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate are mixed to obtain the barrier repair composition.
- Embodiments 6-10 provide 5 kinds of barrier repair compositions, and the only difference from Embodiment 1 is that the examples of calcium salts, magnesium salts, potassium salts, sodium salts and manganese salts with higher parts by weight are provided respectively.
- the preparation method is the same as in Example 1; the raw materials for the preparation of the barrier repair composition described in each embodiment are composed of the following components in parts by weight:
- Embodiments 11-15 provide 5 kinds of barrier repair compositions, and the only difference from Embodiment 1 is that they provide examples with low parts by weight of any one of calcium salt, magnesium salt, potassium salt, sodium salt and manganese salt , the preparation method is the same as in Example 1; the raw materials for the preparation of the barrier repair composition described in each embodiment are composed of the following components in parts by weight:
- Example 16 provides a barrier repair composition, the only difference from Example 1 is that casein is replaced by glycoprotein of the same weight, and other components and preparation methods are the same as in Example 1.
- Comparative Examples 1-5 provide 5 kinds of barrier repair compositions, the only difference from Preparation Example 1 is that there is no example of any one of calcium salt, magnesium salt, potassium salt, sodium salt and manganese salt, and the preparation method is the same as that of Preparation Example 1;
- the raw materials for the preparation of the barrier repair composition described in each comparative example consist of the following components in parts by weight:
- Comparative Examples 6-10 provide 4 kinds of barrier repair compositions, the only difference from Preparation Example 1 is that they lack inorganic salts (calcium salts, magnesium salts, potassium salts, sodium salts and manganese salts), glucose, protein, folic acid and multiple An example of any one of the alcohols, other components and preparation methods are the same as Preparation Example 1; the preparation raw materials of the barrier repair composition described in each comparative example are composed of the following components in parts by weight:
- Test samples barrier repair compositions provided by Examples 1-16 and Comparative Examples 1-10
- Test method Escherichia coli, Lactobacillus and Lactobacillus acidophilus were inoculated into the agar nutrient medium containing 5% of the barrier repair composition provided by the test sample at a ratio of 1:1:1 of viable bacteria (for the formula, see “Disinfection Technology Specification "(2002 version)), after culturing for 24 hours according to the standard method, the number of colonies of each bacterial population was counted.
- By co-cultivating skin resident bacteria and pathogenic bacteria that cause micro-ecological balance damage in the same environment simulating the actual situation of skin flora under the condition of drug administration to patients, and illustrating the composition of the present application for the changes in the abundance of different flora.
- the pharmacological effect of up-regulating the resident flora and down-regulating the pathogenic flora; change value the proportion of the number of strains after cultivation - the proportion of the number of strains before cultivation;
- the barrier repair composition provided by the present application reduced the proportion of E. coli strains by 3.23-4.89%, and the proportion of Lactobacillus strains increased by 5.05-10.63%.
- the proportion of the number of lactobacillus strains has increased by 4.28-8.09%;
- the barrier repair composition provided by the preferred technical solution has reduced the proportion of Escherichia coli strains by 3.23-4.89%, and the proportion of the number of lactic acid bacteria strains has increased 8.64-10.63%, and the proportion of Lactobacillus acidophilus strains increased by 6.54-8.09%.
- the barrier repair composition provided in Example 1-16 can effectively promote probiotics (Lactobacillus, Lactobacillus acidophilus ), inhibit the growth of harmful bacteria (Escherichia coli), indicating that in the barrier repair composition provided by the application, glucose, inorganic salts, protein, folic acid, polyol, bacillus/soybean fermentation product extract and sodium hyaluronate Synergistically, under the condition of ensuring safety and non-irritation, it can inhibit the growth of harmful microorganisms, promote the growth of probiotics, maintain the ecological balance of the skin surface, and thus build a microbial barrier on the skin surface.
- probiotics Lactobacillus acidophilus
- harmful bacteria Esscherichia coli
- Example 1 From the comparison of Example 1 and Comparative Examples 1-5, it can be seen that the type of inorganic salt has a great influence on the efficacy of the barrier repair composition to regulate the balance of skin flora.
- the barrier repair composition When lacking any one of calcium salt, magnesium salt, potassium salt, sodium salt and manganese salt, it is not conducive to the barrier repair composition to play a role in maintaining the balance of skin surface flora, indicating that the components in the inorganic salt cooperate with each other, Synergy.
- Example 1 From the comparison of Example 1 and Examples 6-15, it can be seen that the weight parts of calcium salt, magnesium salt, potassium salt, sodium salt and manganese salt in the inorganic salt will affect the function of the barrier repair composition to build the microbial barrier on the skin surface.
- concentration of various salts When the concentration of various salts is high or low, it is not conducive to promoting the growth of probiotics. This may be because only when the concentrations of calcium salts, magnesium salts, potassium salts, sodium salts and manganese salts in the barrier repairing composition are similar to those in amniotic fluid, the skin surface can be constructed under the synergistic effect of glucose, folic acid and protein. microbial barrier.
- Example 1 From the comparison of Example 1 and Example 16, it can be seen that the choice of protein will affect the efficacy of the barrier repair composition, and the growth of lactic acid bacteria is inhibited when casein is replaced by glycoprotein of the same weight.
- Example 1 Through the comparison of Example 1 and Comparative Examples 6-10, it can be seen that when any component in inorganic salts, glucose, folic acid, protein and polyols is lacking, the efficacy of the barrier repair composition will be seriously affected, and the probiotics will be seriously affected.
- the growth of bacteria will affect the effect of inhibiting the growth of harmful bacteria to a certain extent; it shows that only when inorganic salts, folic acid, protein, glucose and polyols cooperate with each other and synergize, can they achieve the ideal effect of regulating the balance of skin flora.
- Test samples barrier repair compositions provided by Examples 1-16 and Comparative Examples 1-10
- Test method Inoculate the glycerol tube of Bifidobacterium infantis into BS medium at a ratio of 1:100, place it in an incubator for static anaerobic cultivation, and the cultivation temperature is 37°C; the next day, press the activated seeds Inoculate it into the barrier repair composition medium provided by the test sample at a ratio of 1:50, place it in an incubator for static anaerobic culture, and set the culture medium of the control group as normal saline; after 48 hours of culture, the Bifidobacterium infantis grows Stop the culture after reaching the plateau stage, take an appropriate amount of medium for OD600 detection (OD600 value can indirectly reflect the growth of microorganisms); take 100 ⁇ L of medium, spread the bacterial liquid on the BS solid medium in the ultra-clean workbench, and apply After the cloth is finished, put it into the anaerobic bag, put it into the anaerobic bag, seal the outlet of the anaerobic bag, and put the anaerobic bag in the
- the barrier repair composition (Example 1-16) provided by the present application promotes the OD600 value between 0.074-0.121, the number of Bifidobacterium infantis between 130-200CFU/mL, and the pH value between 4.52- Between 4.89; the barrier repair composition provided by the preferred technical scheme (embodiment 1-5) promotes the OD600 value between 0.104-0.121, the number of Bifidobacterium infantis is between 180-200CFU/mL, and the pH value is between 4.52-4.78 between.
- the barrier repair composition mentioned in Example 1-16 can significantly promote the growth of Bifidobacterium infantis;
- inorganic salts, folic acid, glucose and protein can cooperate with each other to effectively promote the growth of Bifidobacterium infantis.
- Example 1 Through the comparison of Example 1 and Comparative Examples 6-10, it can be known that the lack of any component in inorganic salts, glucose, protein, folic acid and polyols will seriously affect the effect of the barrier repair composition on promoting the growth of Bifidobacterium infantis; Especially in the absence of inorganic salts, the barrier repair composition failed to promote the growth of Bifidobacterium infantis.
- Test samples barrier repair compositions provided by Examples 1-16 and Comparative Examples 1-10
- Test method Inoculate Lactobacillus glycerol tubes into MRS medium at a ratio of 1:100, place them in an incubator at a temperature of 37°C; the next day, inoculate activated seeds at a ratio of 1:50 to the test sample
- the culture medium of the barrier repair composition provided, it is placed in an incubator for culture, and the culture medium of the control group is set as physiological saline.
- OD600 value can indirectly reflect the growth of microorganisms, the higher the OD600, the better the growth of microorganisms);
- the barrier repair composition (Example 1-16) provided by the present application is used as a culture medium for Lactobacillus, the OD600 value is between 0.199-0.270 at 6h, and the OD600 value at 24h is 0.498-0.531 Between, the OD600 value is between 0.509-0.619 at 30h, and the OD600 value is between 0.559-0.710 at 48h; , the OD600 value is between 0.224-0.270 at 6h, 0.508-0.531 at 24h, 0.579-0.619 at 30h, and 0.663-0.710 at 48h.
- the lactobacilli in the samples of the barrier repair composition provided in Examples 1-16 as culture medium were higher than those in the blank control group, indicating that the barrier repair composition provided by the present application can promote probiotics. growth of Lactobacillus.
- the barrier repair composition provided in Examples 1-16 can significantly promote the growth of Lactobacillus; it shows that in the barrier repair composition provided by the present application, inorganic salts, folic acid , glucose, protein and polyols can cooperate with each other to effectively promote the growth of Lactobacillus.
- the preparation raw material of described skin care product comprises the following composition by weight part:
- the preparation method of the skin care product comprises the following steps: according to the amount of the formula, heating the water to 85°C, keeping it warm for 30 minutes, then cooling down to 40°C, adding PEG-7 olive oil ester, laureth-12/white pool flower seed Oil, ceramide, polyquaternium-57, barrier repair composition, sodium benzoate, phenoxyethanol, vetiver essential oil and PEG-40 hydrogenated castor oil, mixed for 20 minutes, then homogenized at 40 ° C for 5 minutes, and finally adopted 800 The objective filter cloth is filtered to obtain the skin care product.
- the preparation raw material of described skin care product comprises the following composition by weight part:
- the preparation method of the skin care product comprises the following steps: heating the water to 82°C, keeping it warm for 32 minutes, then cooling down to 35°C, adding PEG-7 olive oil ester, laureth-12/white pond flower seed oil, and ceramide , polyquaternium-57, barrier repair composition, sodium benzoate, phenoxyethanol, vetiver essential oil and PEG-40 hydrogenated castor oil, mixed for 22 minutes, then homogenized at 35°C for 6 minutes, and finally filtered with 800-mesh filter cloth , to obtain the skin care product.
- the preparation raw material of described skin care product comprises the following composition by weight part:
- the preparation method of the skin care product comprises the following steps: heating the water to 87°C, keeping it warm for 33 minutes, then cooling down to 37°C, adding PEG-7 olive oil ester, laureth-12/white pond flower seed oil, and ceramide , polyquaternium-57, barrier repair composition, sodium benzoate, phenoxyethanol, vetiver essential oil and PEG-40 hydrogenated castor oil, mixed for 20 minutes, then homogenized at 37°C for 4.5 minutes, and finally filtered with 800-mesh filter cloth , to obtain the skin care product.
- the preparation raw material of described skin care product comprises the following composition by weight part:
- the preparation method of the skin care product comprises the following steps: heating the water to 88°C, keeping it warm for 29 minutes, then cooling down to 42°C, adding PEG-7 olive oil ester, laureth-12/white pond flower seed oil, and ceramide , polyquaternium-57, barrier repair composition, sodium benzoate, phenoxyethanol, vetiver essential oil and PEG-40 hydrogenated castor oil, mixed for 20 minutes, then homogenized at 42°C for 5 minutes, and finally filtered with 800-mesh filter cloth , to obtain the skin care product.
- the preparation raw material of described skin care product comprises the following composition by weight part:
- the preparation method of the skin care product comprises the following steps: heating the water to 82°C, keeping it warm for 26 minutes, then cooling down to 38°C, adding PEG-7 olive oil ester, laureth-12/white pond flower seed oil, and ceramide , polyquaternium-57, barrier repair composition, sodium benzoate, phenoxyethanol, vetiver essential oil and PEG-40 hydrogenated castor oil, mixed for 30 minutes, then homogenized at 38°C for 7 minutes, and finally filtered with 800-mesh filter cloth , to obtain the skin care product.
- This application example provides a skin care product, the only difference from application example 1 is that the weight part of the barrier repair composition is reduced to 20 parts, and other components and preparation methods are the same as application example 1.
- This application example provides a skin care product, the only difference from application example 1 is that the weight part of the barrier repair composition is increased to 50 parts, and the other components and preparation methods are the same as application example 1.
- Application examples 8-9 provide two kinds of skin care products, the only difference from application example 1 is that they lack any examples of PEG-7 olive oil ester or laureth-12/white pond flower seed oil respectively, and the preparation method is the same Application example 1; the preparation raw materials of the barrier repair composition described in each application example are composed of the following components in parts by weight:
- Comparative application examples 1-3 provide three skin care products, the only difference from application example 1 is that there is no example of any one of oil, ceramide or barrier repair composition, and the other components and preparation methods are the same as application example 1 , the preparation raw materials of the skin care products described in each comparative application example are composed of the following ingredients in parts by weight:
- Test sample the skin care products provided by Application Examples 1-9 and Comparative Application Examples 1-3
- Test method 120 volunteers with dry forearm skin between the ages of 18 and 30 were selected as subjects. The subjects were divided into 12 groups, with 10 people in each group. The inclusion condition was that the moisture content of the inner forearm was less than 45; Before using the product, mark the test area for the subject; use the sample in different areas, the product volume is (2.0 ⁇ 0.1) uL/cm 2 , the test site is the forearm internal test; the test index is the transcutaneous water loss value (TEWL value) , Test time points: before use, two weeks and four weeks after use.
- TEWL value transcutaneous water loss value
- change value 1 average transdermal water loss value after two weeks of use - average transdermal water loss value before use
- change value 2 average transdermal water loss value after four weeks of use - Average transcutaneous water loss value before use
- Test sample skin care products provided by application examples 1-18 and comparative application examples 1-12
- Test method According to the standard of "SN/T 2329-2009 Cosmetic Eye Irritation/Corrosion Test on Chicken Embryo Allantoic Membrane", take 0.3mL of skin care products provided by the test sample and drop directly on the surface of the chicken embryo allantoic membrane , Observe and record the chorioallantoic membrane toxicity effect indicators (such as bleeding, coagulation and blood vessel melting) after 5 minutes of action. These indicators reflect the changes in the morphological structure, color and permeability of blood vessels and vascular network, as well as the phenomenon of chorioallantoic membrane protein denaturation and the degree of damage. These are then combined to obtain a score for evaluating the eye irritation of the test substance.
- chorioallantoic membrane toxicity effect indicators such as bleeding, coagulation and blood vessel melting
- Stimulus score method For tests conducted using the reaction time method, the calculation formula for calculating the stimulus score (IS) is:
- secH bleeding time
- secL vascular melting time
- secC coagulation time
- Test sample the skin care products provided by Application Examples 1-9 and Comparative Application Examples 1-3
- Test method Firstly, 24 hours before the test, the two eyes of the experimental animals were routinely checked. During the test, the lower eyelid of one side of the eye of the experimental animal was gently opened, 0.1 mL of the test sample was sucked and dropped into the conjunctival sac, and the eyes were passively closed for 1 second. Treated as self-control; 1h, 24h, 48h, 72h, 4d, 7d, 14d and 21d after the end of the test, the eyes were checked and scored, if there was no irritation within 72h, or the eyes completely recovered on the 7th or 14th day, Trials may be terminated early. The cornea was examined with 2% sodium fluorescein when necessary.
- the irritation response score was calculated. According to the irritation response score and recovery time evaluation, the eye irritation response was graded according to Table 7.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
La présente demande concerne une composition de réparation de barrière, un produit de soins de la peau et un procédé de préparation et une utilisation associés dans la préparation d'une lingette humide. La composition de réparation de barrière comprend les matières premières suivantes, en parties en poids : 0,01 à 9 parties de sels inorganiques, 0,1 à 1 partie de glucose, 0,5 à 2 parties de protéine, 0,0001 à 0,05 partie d'acide folique, 0,01 à 0,5 partie d'un polyol et 800 à 1200 parties d'eau, les sels inorganiques comprenant un sel de calcium, un sel de magnésium, un sel de potassium, un sel de sodium et un sel de manganèse. Le produit de soins de la peau comprend les matières premières suivantes : des lipides, de la céramide, du polyquaternium, la composition de réparation de barrière mentionnée ci-dessus et de l'eau. La composition de réparation de barrière selon la présente demande est sûre et non irritante. Au moyen de la composition de réparation de barrière, une barrière microbienne est établie sur la surface de la peau par promotion de l'établissement d'un équilibre microécologique sur la surface de la peau, et la barrière physique de la peau est améliorée par apport nutritif et d'humidité à la peau.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180003553.0A CN114173751B (zh) | 2021-11-03 | 2021-11-03 | 一种屏障修复组合物、护肤品及其制备方法和在制备湿巾中的应用 |
PCT/CN2021/128346 WO2023077291A1 (fr) | 2021-11-03 | 2021-11-03 | Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2021/128346 WO2023077291A1 (fr) | 2021-11-03 | 2021-11-03 | Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023077291A1 true WO2023077291A1 (fr) | 2023-05-11 |
Family
ID=80489973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/128346 WO2023077291A1 (fr) | 2021-11-03 | 2021-11-03 | Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN114173751B (fr) |
WO (1) | WO2023077291A1 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
CN111514173A (zh) * | 2019-02-01 | 2020-08-11 | 宝龄富锦生技股份有限公司 | 修复皮肤屏障的组合物及其用途 |
CN112426393A (zh) * | 2020-12-04 | 2021-03-02 | 维尼健康(深圳)股份有限公司 | 一种婴儿专用全棉湿巾 |
CN113476346A (zh) * | 2021-06-16 | 2021-10-08 | 西安德诺海思医疗科技有限公司 | 一种皮肤屏障修复组合物 |
-
2021
- 2021-11-03 WO PCT/CN2021/128346 patent/WO2023077291A1/fr unknown
- 2021-11-03 CN CN202180003553.0A patent/CN114173751B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
CN111514173A (zh) * | 2019-02-01 | 2020-08-11 | 宝龄富锦生技股份有限公司 | 修复皮肤屏障的组合物及其用途 |
CN112426393A (zh) * | 2020-12-04 | 2021-03-02 | 维尼健康(深圳)股份有限公司 | 一种婴儿专用全棉湿巾 |
CN113476346A (zh) * | 2021-06-16 | 2021-10-08 | 西安德诺海思医疗科技有限公司 | 一种皮肤屏障修复组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN114173751A (zh) | 2022-03-11 |
CN114173751B (zh) | 2023-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110585114B (zh) | 一种调节皮肤微生物菌群的杀菌组合物及其应用 | |
CN110638740A (zh) | 一种具有调节皮肤微生态的组合物及其应用 | |
CN105902461A (zh) | 一种含蜗牛粘液提取物的精华液及其制备方法 | |
CN105853260B (zh) | 一种尿布皮炎霜及其制备方法 | |
CN105560155A (zh) | 含有山羊奶的化妆品组合物及其应用 | |
US20200093726A1 (en) | Compound additive having biological activation function, preparation method therefor and use thereof | |
JP2004511524A (ja) | 松花の花粉または松花の花粉抽出物を含有する皮膚外用剤 | |
KR101985381B1 (ko) | 포도, 오렌지, 사과, 레몬 및 라임을 발효하여 만든 과일 발효액 콤플렉스를 함유하는 피부 각질 박리용 화장료 조성물 | |
CN108186426B (zh) | 一种抑菌面膜液、面膜及其制备方法 | |
CN116617115B (zh) | 一种温和无泪的活性成分组合物及其在洗护产品中的应用 | |
CN108815100A (zh) | 含有艾叶干细胞提取物的抑菌止痒护肤品及其制备方法 | |
CN113786371A (zh) | 一种制备越橘海藻面膜的组合物、面膜及制备方法 | |
WO2023077291A1 (fr) | Composition de réparation de barrière, produit de soins de la peau et procédé de préparation et utilisation associés dans la préparation d'une lingette humide | |
KR20150122983A (ko) | 박하초를 함유하는 화장료 조성물 | |
CN111904909A (zh) | 一种含有玫瑰发酵液的去屑头皮精华及其制备方法 | |
JP6382815B2 (ja) | 保湿剤 | |
CN114469817B (zh) | 细致毛孔组合物及其制备方法和应用 | |
CN105853295A (zh) | 一种用于儿童皮肤粘膜炎症护理的外用制剂及其应用 | |
CN117257695A (zh) | 发酵水油双层组合物及其制备方法与应用 | |
CN106511153B (zh) | 一种具有祛痘功效的纳米组合物及其化妆品或护肤品 | |
CN111040896A (zh) | 一种抗菌消炎美肤手工皂 | |
CN113244140A (zh) | 一种调节皮肤微生态平衡的组合物及其应用与制备方法 | |
CN108852977B (zh) | 一种晶润精华液 | |
US20220080000A1 (en) | Product for the treatment of dysbiosis | |
CN112057414A (zh) | 一种水漾保湿双酵精萃面膜 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21962811 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |